Case Report of Rapidly Fatal Serratia marcescens Necrotizing Fasciitis

Monday, March 23, 2026

10:15 AM - 11:15 AM Central Time

Location: Connections Central - RST 16

LS

Lindsay Olivia Stepp, MD, FACS (she/her/hers)

Ohio State University, Ohio

Disclosure(s): No relevant financial relationship(s) to disclose.
KD

Kate Doubek, AGACNP-BC

Critical Care Nurse Practitioner
Washington University in St. Louis

Disclosure information not submitted.
AS

Alexandra Smith, PA-C

Emergency Medicine Physician Assistant
Gallup Indian Medical Center, New Mexico

Disclosure information not submitted.
IO

Ifeanyichukwu Okereke, MD

General Surgery Resident Physician
Washington University in St. Louis

Disclosure information not submitted.
IT

Isaiah Turnbull, MD, PhD, FCCM

Associate Professor of Surgery
Washington University in Saint Louis School of Medicine

Disclosure information not submitted.
LK

Lindsay M. Kranker, MD, FACS

Assistant Professor of Surgery
Washington University of Saint Louis

Disclosure information not submitted.

Introduction: Necrotizing soft tissue infections (NSTIs) are aggressive infections involving skin, fascia, and muscle, with mortality rates of 25–30%. Pathogenesis includes infection, toxin production, cytokine release, and tissue ischemia. NSTIs may occur without trauma, particularly in immunosuppressed hosts. Serratia marcescens, a gram-negative opportunistic pathogen, is rarely implicated in monomicrobial NSTIs.

Description: A 67-year-old woman with rheumatoid arthritis on golimumab, CKD-4, type 2 diabetes, and transfusion-dependent anemia presented with fever, hypotension, and left calf pain. She had a history of recurrent urinary tract infections. Labs revealed neutropenia (WBC 0.5 K/μL), creatinine 6.66 mg/dL, and lactate 3.8 mmol/L. CT showed nonspecific subcutaneous edema without gas or fluid collection. LRINEC score was 4. She was transferred to a tertiary ICU and rapidly progressed to vasoplegic shock requiring triple vasopressors/inotropes and stress-dose steroids. Her left leg was erythematous, tender, and showed progression beyond marked borders. Emergent exploration revealed extensive necrosis with “dishwater fluid” and thrombosed fascia, confirming NSTI. Aggressive excisional debridement of skin, fascia, and muscle was performed. Postoperatively, her multi-organ failure worsened, requiring continuous renal replacement despite broad antimicrobial therapy (meropenem, vancomycin, clindamycin, tobramycin). A second excisional debridement was performed at 12-hours, but her refractory acidosis worsened and she died following transition to comfort measures.

Discussion: Monomicrobial S. marcescens NSTI is exceedingly rare, with only 17 cases reported. This patient's profound immunosuppression from golimumab likely predisposed her to this pathogen and blunted classic inflammatory signs. TNF-α plays a central role in immune response; its blockade impairs pathogen clearance and immune activation. Imaging and LRINEC were falsely reassuring in this case—emphasizing the limitations of these tools in immunocompromised patients. Serratia’s ability to produce beta-lactamase and cause severe infection highlights the need for rapid surgical intervention and broad antimicrobial coverage. This case underscores the potential for atypical, fulminant infections in TNF-α-inhibited hosts.